Bajaj Healthcare launches Black Fungus API By Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below are Quote on Bajaj Healthcare launches Black Fungus API by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
Bajaj Healthcare Limited, a leading manufacturer of APIs, Intermediates and Formulations, has announced the launch of Posaconazole API used in treating Mucormycosis (Black Fungus) infection in Covid-19 patients. Bajaj Healthcare has received approval from FDA Gandhi Nagar, Gujarat India, to manufacture and market “Posaconazole API” as approved medication for treating Mucormycosis in India and it will commence its commercial production from 1 st week of June 2021.
Mucormycosis cases have increased in India in the 2nd wave of Covid 19 Pandemic, as of now 4 states have the majority of Mucormycosis cases but not its spreading across India. Already several companies have launched drugs for treatment of Mucormycosis but there is a shortage of its API. This launch of Posaconazole API will be in good demand in the coming quarter.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
